Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, a minor UI/version update with no changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:10:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A glossary toggle was added to the page, and several textual updates were made, including capitalizing 'Last Update Submitted that Met QC Criteria' and updating the label to 'No FEAR Act Data' with the revision now listed as v3.4.0. The previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:32:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4; no substantive changes to study details, eligibility criteria, or results are evident.
    Difference
    0.0%
    Check dated 2026-01-14T03:37:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added and updated study locations (Colorado, Maryland, Michigan, Ontario, Quebec, Gran Canaria, Madrid) and reorganized site listings. The page revision label changed to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T21:04:43.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Updated Publications section wording to clarify that publications are provided by the submitting party and pertain to study results. Added template revision indicator Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:18:14.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Removal of the government funding/operating status notice from the page; it does not affect trial details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:46:54.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.